Ayman Saad, MD
Assistant Professor of Medicine
Dr. Saad joined the Medical College of Wisconsin in 2008 as an Assistant Professor of Medicine in the Division of Neoplastic Diseases and Related Disorders. He obtained his medical degree in Ain Shams University, Egypt in 1994, Dr. Saad did an internship and residency in Radiation and Clinical Oncology in Ain Shams University. He then was as an assistant lecturer in Ain Shams University School of Medicine till 2000.
Dr. Saad was a clinical research fellow (2000-2002) at Wayne State University, Detroit, Michigan. He completed an Internal Medicine residency at the University of Maryland/Maryland General Hospital in 2005. He finished a Hematology and Medical Oncology fellowship in West Virginia University in 2008. During the fellowship, he worked in the cancer biology research laboratory investigating the development of new targeted therapy for multiple myeloma. He authored many journal publications, national meeting presentations, and book chapters.
In 2007, he received the Merit Award from the American Society of Clinical Oncology. He also received Margaret Albrink Research Award in 2007 from West Virginia University School of Medicine. Dr. Saad was honored as Fellow of the Year in 2007 and 2008 by the Division of Hematology and Oncology in West Virginia University School of Medicine.
Dr. Saad specializes in the treatment of patients with lymphoid and plasma cell disorders.
His main research interest is focused on the development of new therapeutic modality that targets the interaction between myeloma cells and microenvironment.
Selected publications and abstracts:
1. Saad A, Sharma M, Higa G. Impact of Tumor Biology on the Treatment of Multiple Myeloma. The Annals of Pharmacotherapy (in press).
2. Saad A, Abraham J. Role of Tumor Markers and Circulating Tumors Cells in the Management of Breast Cancer. Oncology. 2008; 22 (7):726-731.
3. Saad A and Abraham J. Trastuzumab and cardiac toxicity: monitoring in the adjuvant setting. Community Oncology. 2007; 4 (12):739-744.
4. Saad A, Almubarak M, Kanate A, Cumpston A, Watkins K, Buckhalter R, Bunner P, Hobbs G, Craig M. Balancing Acute Graft Versus Host Disease (aGVHD) and Survival after Peripheral Allogeneic Stem Cell Transplantation (SCT) in Hematological Malignancies: A Potential for Graft Engineering. Proceedings of the 49th Annual Meeting of the American Society of Hematology. 2007; 3285.
5. Saad A, Fortney J, Wang L, O’Leary H, Ericson S, Gibson L. Disruption of the crosstalk CXCL12/CXCR4 chemotactic pathway to enhance melphalan-induced apoptosis in multiple myeloma cell lines. Proceedings of the 48th Annual Meeting of the American Society of Hematology. 2006; 3445.
6. Saad A, Rhoades A, Yousuf S, Heyman M. A case of multiple myeloma presented with stridor: A rare case report. Proceedings of the 39th Annual meeting of the American Society of Clinical Oncology. 2003; 2442.
Book Chapters:
1 Ayman Saad, Robert Beto, Jame Abraham, Scot Remick. Cardiovascular Safety and Toxicity Profile of New Molecularly Targeted Anticancer Agents. Educational Book of the American Society of Clinical Oncology (ASCO) meeting. 2008; 428-434
2 Ayman Saad, Michael Craig. Hodgkin Lymphoma. Bethesda Handbook of Clinical Oncology. Third edition, 2008 (in press).